Trial intelligence / Profile preview

Coppertone (BAY987704) SPF and UVAPF Efficacy Study

NCT02756988Completed

Sponsor
Bayer
Start
Oct 2015
Primary completion
Oct 2015
Modality
Transdermal Patches, Hydrogel Systems, Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of BAY987517 in sunburn, sponsored by Bayer. Primary endpoints: Minimal Erythema Dose up to 15 minutes and Minimal Persistent Pigment Darkening Dose up to 15 minutes. Started Oct 2015; status: completed.

02

Drugs

BAY987517
03

Conditions

sunburn

Beyond the preview

Go deeper on NCT02756988.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02756988.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call